John D. Ash, PhD

Dr. John D. Ash is a distinguished scientist, educator, and leader in vision science. He holds the E. Ronald Salvitti Chair in Ophthalmology Research at the University of Pittsburgh School of Medicine and serves as Vice Chair of Ophthalmology, overseeing research and academic development within the department. Over more than two decades, Dr. Ash has established himself as an expert in retinal degeneration, with research focused on the molecular mechanisms underlying vision loss in inherited retinal diseases and age-related macular degeneration (AMD). His pioneering work on neuroprotective cytokines, retinal metabolism, and the role of AMP-activated protein kinase (AMPK) in retinal homeostasis has fundamentally advanced our understanding of how the retina responds to stress and injury, and how those responses contribute to degenerative disease. His discoveries have directly shaped therapeutic strategies for retinal disease. Most notably, his findings implicating the FDA-approved drug metformin in retinal protection have spurred ongoing clinical trials led by the National Eye Institute, underscoring the translational impact of his laboratory work.

In 1999, Dr. Ash began his academic career as an Assistant Professor in the Department of Ophthalmology at the University of Oklahoma Health Sciences Center. He was promoted to Associate Professor in 2006 and received full Tenure in 2007. In 2011, Dr. Ash moved to the University of Florida as the Francis M. Bullard Eminent Scholar Chair in Ophthalmic Sciences in the Department of Ophthalmology at the University of Florida. In 2022, Dr. Ash moved to the University Pittsburgh School of Medicine to become the E. Ronald Salvitti Professor of Ophthalmology Research, where he also serves as the Vice-Chair and Director of Research.